hPMSCs prevent erythrocytes dysfunction caused by graft versus host disease via promoting GSH synthesis
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112689 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yanlian Xiong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, School of Basic Medicine, Binzhou Medical University, Yantai, PR China. Hauptthemen laut MEDLINE: Graft vs Host Disease, Mice, Inbred BALB C, Erythrocytes, Mesenchymal Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Oxidative stress is increased in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients and leads to the development of graft versus host disease (GVHD). Mesenchymal stromal cells (MSCs) can ameliorate GVHD by regulating the function of T cells. However, whether MSCs can modulate erythrocyte antioxidant metabolism and thus reduce GVHD is not known. METHODS: Forty female BALB/c mice were randomly assigned to four groups: the control, GVHDhigh, hPMSC, and PBS groups. A hypoxanthine/xanthine oxidase system was used to steadily and gradually produce superoxide in an in vitro experiment. A scanning microscope was used to examine the ultrastructure of erythrocytes. Laser diffraction analyses were used to analyze erythrocyte deformability. Western blotting was used to measure the expression of the erythrocyte membrane skeleton proteins Band 3 and β-Spectrin. Corresponding kits were used to assess the levels of oxidative damage and the activity of antioxidant enzymes. RESULTS: Morphological and deformability defects were significantly increased in erythrocytes from GVHD patients. Band 3 and β-Spectrin expression was also reduced in GVHD patients and model mice. Furthermore, we observed significantly increased oxidative stress-induce injury and decreased antioxidant capability in erythrocytes from both GVHD patients and model mice. Subsequent research showed that human placenta-derived MSC (hPMSC) therapy decreased the GVHD-induced redox imbalance in erythrocytes. Furthermore, our findings suggested that upregulating glucose metabolism promoted both the de novo synthesis and recycling of GSH, which is the primary mechanism by which hPMSCs mediate the increase in antioxidant capacity in erythrocytes. CONCLUSION: Together, our findings suggest that hPMSCs can increase antioxidant capacity by increasing erythrocyte GSH production and thus ameliorate GVHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, School of Basic Medicine, Binzhou Medical University, Yantai, PR China.
- Department of Anesthesiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, PR China.
- Department of Immunology, School of Basic Medicine, Binzhou Medical University, Yantai, PR China.
- Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong Province 264000, PR China.
- Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong Province 264000, PR China. Electronic address: rongxiawei@126.com.
- Department of Immunology, School of Basic Medicine, Binzhou Medical University, Yantai, PR China. Electronic address: xiying_luan@163.com.
Förderung
- Shandong Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Xiong, Y., Wang, F., Mu, H., Zhang, A., Zhao, Y., Han, K., Zhang, J., Zhang, H., Wang, Z., Ma, J., Wei, R., & Luan, X. (2024). hPMSCs prevent erythrocytes dysfunction caused by graft versus host disease via promoting GSH synthesis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112689
Vancouver
Xiong Y, Wang F, Mu H, Zhang A, Zhao Y, Han K, et al. hPMSCs prevent erythrocytes dysfunction caused by graft versus host disease via promoting GSH synthesis. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112689
BibTeX
@article{Xiong2024,
author = {Xiong, Yanlian and Wang, Feifei and Mu, Huanmei and Zhang, Aiping and Zhao, Yaxuan and Han, Kaiyue and Zhang, Jiashen and Zhang, Hengchao and Wang, Zhuoya and Ma, Junjie and Wei, Rongxia and Luan, Xiying},
title = {hPMSCs prevent erythrocytes dysfunction caused by graft versus host disease via promoting GSH synthesis},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112689}
}
EUVIMED